References
- Hviid A, Rubin S, Mulemann K. Mumps. Lancet 2008; 371(9616): 932-944 https://doi.org/10.1016/S0140-6736(08)60419-5
- Centers for Disease Control and Prevention. Mumps. In: Centers for Disease Control and Prevention, editors. Epidemiology and Prevention of Vaccine-preventable Diseases: Pink Book. 10th ed. Wahsington, DC: Public Health Foundation; 2008. p. 149-158
- Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and rubella eliminated from Finland. JAMA 2000; 284(20): 2643-2647 https://doi.org/10.1001/jama.284.20.2643
- World Health Organization. Global status of mumps immunization and surveillance. Wkly Epidemiol Rec 2005; 80(48): 418-424
- Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: A global review. Bull World Health Organ 1999; 77(1): 3-14
- Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. Washington DC: Department of Health and Human Services; 2000 [cited 2009 Jan 22]. Available from: URL: www. healthypeople.gov/document/html/objectives/14-01.htm
- Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ 2005; 330(7500): 1132-1135 https://doi.org/10.1136/bmj.330.7500.1132
- Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF. Two successive outbreaks of mumps in nova scotia among vaccinated adolescents and young adults. CMAJ 2006; 175(5): 483-488 https://doi.org/10.1503/cmaj.060660
- Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358(15): 1580-1589 https://doi.org/10.1056/NEJMoa0706589
- Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: Time for new thinking on mumps vaccines. Clin Infect Dis 2007; 45(4): 459-466 https://doi.org/10.1086/520028
- Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis 2008; 47(11): 1458-1467 https://doi.org/10.1086/591196
- Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 2008; 46(8): 1172-1180 https://doi.org/10.1086/529141
- Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13(1): 12-17
- Vandermeulen C, Mathieu R, Geert LR, Pierre VD, Karel H. Long-term persistence of antibodies after one or two doses of MMRvaccine. Vaccine 2007; 25(37-38): 6672-6676 https://doi.org/10.1016/j.vaccine.2007.07.008
- Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: A 20-year follow-up. J Infect Dis 2008; 197(7): 950-956 https://doi.org/10.1086/528993
- Baum SG. Editorial commentary: Who cares about mumps? You should! Clin Infect Dis 2008; 46(9): 1450-1451 https://doi.org/10.1086/587105
- Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, LeBaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students- Iowa, 2006. Vaccine 2008; 26(29-30): 3601-3607 https://doi.org/10.1016/j.vaccine.2008.04.075
- Gemmill I. Mumps vaccine: Is it time to reevaluate our approach? CMAJ 2006; 175(5):491-492 https://doi.org/10.1503/cmaj.060900
- Soud FA, Cortese MM, Curns AT, Edelson PJ, Bitsko RH, Jordan HT, et al. Isolation compliance among university students during a mumps outbreak, Kansas 2006. Epidemiol Infect 2009; 137(1): 30-37 https://doi.org/10.1017/S0950268808000629
- Borchardt S, Rao P, Dworkin M. Compliance with exclusion requirements to prevent mumps transmission. Emerg Infect Dis 2007; 13(10): 1617-1618 https://doi.org/10.3201/eid1310.070117
- Richardson M, Elliman D, Maguire H, Simpson J, Nicoll A. Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J 2001; 20(4): 380-391 https://doi.org/10.1097/00006454-200104000-00004
- Centers for Disease Control and Prevention. Updated recommendations for isolation of persons with mumps. MMWR Morb Mortal Wkly Rep 2008; 57(40): 1103-1105
- Polgreen PM, Bohnett LC, Cavanaugh JE, Gingerich SB, Desjardin LE, Harris ML, et al. The duration of mumps virus shedding after the onset of symptoms. Clin Infect Dis 2008; 46(9): 1447-1449 https://doi.org/10.1086/587104
- Korea Centers for Disease Control and Prevention, Korean Medical Association, Korea Advisory Committe on Immunization Practices. Epidemiology and Prevention of Vaccine-prevantable Disease. Seoul: Korea Centers for Disease Control and Prevention; 2006. p. 163-202. (Korean)
- Choi BY, Shin YJ, Son JI, Ki M, Oh YW, Bang KN, et al. Epidemiological study on the mumps epidemic - in one primary school in Hwasung-gun, Kyonggi-do. Korean J Epidemiol 1995; 17(1): 105-115. (Korean)
- Kim MH, Ki M, Hu YJ, Choi BY. An epidemiologic investigation on mumps outbreak in Cheju-do, 1998. Korean J Prev Med 2001; 34(1): 89-99. (Korean)
- Park BC, Cheong HK, Lim HS, Kim DS, Kim Dh. Epidemiologic investigation of a mumps outbreak in a middle school in Pohang, Korea. Korean J Epidemiol 2000; 22(2): 148-158. (Korean)
- Korea Centers for Disease Control and Prevention. 2007 Communicable Diseases Surveillance Yearbook. Seoul: Korea Centers for Disease Control and Prevention; 2008. (Korean)
- Ki M, Kim CH, Choi BY, Kang C, Lee DH, Park O, et al. Evaluation of mumps outbreak and serology. Seoul: Korea Center for Diseases Control and Prevention; 2008. (Korean)
- Kim KH, Ki H, Choi BY, Kim CH, Lee DH, Ko UY, et al. Evaluation of mumps vaccine effectiveness by outbreak investigation in one kindergarten in Ulsan city, 2006. Korean J Epidemiol 2008; 30(1): 110-118. (Korean) https://doi.org/10.4178/kje.2008.30.1.110
- Savitz DA, Measurement and classification of exposure. In: Savitz DA, editor. Interpreting Epidemiologic Evidence: Strategies for Study Design and Analysis. 1st ed. New York: Oxford University Press; 2003. p. 163-204
- Centers for Disease Control and Prevention, editor. Manual for the Surveillance of Vaccinepreventable Diseases. 4th ed. Atlanta: Disease Control and Preven-tion; 2008
- Plotkin S, Wharton M. Mumps vaccine. In: Plotkin AP, Offit PA, Orenstein WA, editors. Vaccines. 5th ed. Philadelphia: WB Saunders; 2008. p. 441-470
- Sanz JC, Mosquera Mdel M, Echevarria JE, Fernandez M, Herranz N, Palacios G, et al. Sensitivity and specificity of immunoglobulin G titer for the diagnosis of mumps virus in infected patients depending on vaccination status. APMIS 2006; 114(11): 788-794 https://doi.org/10.1111/j.1600-0463.2006.apm_463.x
- Krause CH, Molyneaux PJ, Ho-Yen DO, McIntyre P, Carman WF, Templeton KE. Comparison of mumps-IgM ELISA in acute infection. J Clin Virol 2007; 38(2): 153-156 https://doi.org/10.1016/j.jcv.2006.10.010
- Choi BY. Epidemiologic characteristics and management of infectious disease. In: Committee on publication of preventive medicine textbook, editor. Preventive Medicine. 3rd ed. Seoul: Gye Chuk Mun Wha Sa Publishing Co.; 2004. p. 177-267. (Korean)
Cited by
- 2013년 서울의 일개 고등학교에서 발생한 유행성 이하선염 집단발병 vol.22, pp.1, 2009, https://doi.org/10.14776/piv.2015.22.1.1